Primary antiphospholipid syndrome with celiac and splenic artery thrombosis
DOI:
https://doi.org/10.18203/2349-3933.ijam20230665Keywords:
APS, Celiac artery thrombosis, SpSplenic infarctionAbstract
Antiphospholipid syndrome (APS) is an autoantibody mediated acquired thrombophilia characterized by recurrent arterial or venous thrombosis and or pregnancy morbidity. We describe a case of 32-year-old female who had a medical history of APLA presented with complaints of abdominal pain for 20 days. On evaluation, CT abdomen contrast revealed celiac and splenic artery thrombosis. She was successfully treated with IV unfractionated heparin, warfarin and antiplatelets.
Metrics
References
Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002;46:1019-27.
Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295-306.
Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost. 1995;74:1185-90.
Pengo V, Tripodi A, Reber G, Rand JH, Ortel TL, Galli M et al. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost. 2009;7:1737-40.
Agar C, van Os GM, Morgelin M, Sprenger RR, Marquart JA, Urbanus RT et al. Beta2- glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome. Blood. 2010;116:1336-43.
Urbanus RT, de Laat B. Antiphospholipid antibodies and the protein C pathway. Lupus. 2010;19:394-9.
Marciniak E, Romond EH. Impaired catalytic function of activated protein C: a new in vitro manifestation of lupus anticoagulant. Blood. 1989;74:2426-32.
Smirnov MD, Triplett DT, Comp PC, Esmon NL, Esmon CT. On the role of phosphatidylethanolamine in the inhibition of activated protein C activity by antiphospholipid antibodies. J Clin Invest. 1995;95:309-16.
Williams FM, Parmar K, Hughes GR, Hunt BJ. Systemic endothelial cell markers in primary antiphospholipid syndrome. Thromb Haemost. 2000; 84:742-6.
Betapudi V, Lominadze G, Hsi L, Willard B, Wu M, McCrae KR. Anti-beta2GPI antibodies stimulate endothelial cell microparticle release via a non-muscle myosin II motor protein dependent pathway. Blood. 2013;122:3808-17.
Redecha P, Tilley R, Tencati M, Salmon JE, Kirchhofer D, Mackman N et al. Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury. Blood. 2007;110:2423-31.
Kelekis NL, Athanassiou E, Loggitsi D, Moisidou R, Tzovaras G, Fezoulidis I. Acute occlusion of the celiac axis and its branches with perforation of gastric fundus and splenic infarction, findings on spiral computed tomography: a case report. Cases J. 2010;3:82.10.1186/1757-1626-3-82.
Alharbi M, Benitez CY, Alharbi AM. Celiac Trunk Thrombosis a Rare Cause of Acute Abdomen. Case Presentation. Cureus. 2022;14(9):e29727.
Choi BG, Jeon HS, Lee SO, Yoo WH, Lee ST, Ahn DS. Primary antiphospholipid syndrome presenting with abdominal angina and splenic infarction. Rheumatol Int. 2002;22(3):119-21.
Genc V, Cetinkaya OA, Kayilioglu I, Karaca AS, Cipe G, Unal AE. Splenic infarction as a complication of celiac artery thromboembolism: an unusual cause of abdominal pain. J Korean Surg Soc. 2011;81(5):360-2.
Uthman I, Khamashta M. The abdominal manifestations of the antiphospholipid syndrome. Rheumatology (Oxford). 2007;46(11):1641-7.
